Aug 04, 2020 / 07:00AM GMT
Unidentified Company Representative -
[Interpreted] Thank you very much for waiting. We are going to begin. Thank you very much for joining this conference call hosted by Astellas Pharma Inc. despite your very busy schedule. I'm [Fujii] from Corporate Advocacy and Relation. I'm delighted to serve as emcee today. We are starting this meeting to explain our financial year 2020 first quarter financial results we announced at noon today. We are going to explain based on materials posted in the IR Library Business Results section on our website, so please refer to the documents.
Let me introduce the participants first. CSTO and CFO, Naoki Okamura. Okamura, thank you for your time. CCO, Yukio Matsui. Matsui, thank you for joining. Development Division, Global Head of Project Management, Minetake Kitagawa.
Mike Kitagawa - Astellas Pharma Inc. - Senior VP of Development Project Management
[Interpreted] Kitagawa speaking. Thank you for your time.
Unidentified Company Representative -
[Interpreted] This material or presentation by
Q1 2021 Astellas Pharma Inc Earnings Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers